Nemluvio is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives itch and is involved in inflammation and skin barrier ...

Quezon City.  Following its exposé on perfumes containing a banned “reprotoxic” synthetic scent ingredient, the EcoWaste ...